Literature DB >> 12429210

Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat.

Ming Yang1, Natalie D Stull, Mathew A Berk, Evan Y Snyder, Lorraine Iacovitti.   

Abstract

The ability to differentiate neural stem cells (NSCs) into dopamine neurons is fundamental to their role in cell replacement therapies for neurodegenerative disorders such as Parkinson's disease. We show here that when a clonal line (C17.2) of undifferentiated NSCs is transplanted into the intact or 6-hydroxydopamine-lesioned striatum, cells withdraw from the cell cycle (BrdU(-)), migrate extensively in the host striatum, and express markers associated with neuronal (beta-tubulin III(+), NSE(+), NeuN(+)) but not glial (GFAP(-), MBP(-), A2B5(-)) differentiation. Importantly, by 2-5 weeks postgrafting, in the majority of these transplants, nearly all engrafted cells express the dopamine-synthesizing enzymes tyrosine hydroxylase and aromatic L-amino decarboxylase, sometimes resulting in changes in motor behavior. In contrast, no NSCs stain for dopamine-beta-hydroxylase, choline acetyltransferase, glutamic acid decarboxylase, or serotonin. We conclude that, following transplantation into the intact or 6-hydroxydopamine-lesioned rat, the adult brain contains intrinsic cues sufficient to direct the specific expression of dopaminergic traits in immature multipotential neural stem cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429210     DOI: 10.1006/exnr.2002.7989

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  29 in total

1.  Different effects of histone deacetylase inhibitors nicotinamide and trichostatin A (TSA) in C17.2 neural stem cells.

Authors:  Haifeng Wang; Hua Cheng; Kai Wang; Tieqiao Wen
Journal:  J Neural Transm (Vienna)       Date:  2012-03-13       Impact factor: 3.575

2.  A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivo.

Authors:  Lorraine Iacovitti; Angela E Donaldson; Cheryl E Marshall; Sokreine Suon; Ming Yang
Journal:  Brain Res       Date:  2006-11-21       Impact factor: 3.252

3.  Neural stem cells injected into the sound-damaged cochlea migrate throughout the cochlea and express markers of hair cells, supporting cells, and spiral ganglion cells.

Authors:  Mark A Parker; Deborah A Corliss; Brianna Gray; Julia K Anderson; Richard P Bobbin; Evan Y Snyder; Douglas A Cotanche
Journal:  Hear Res       Date:  2007-06-20       Impact factor: 3.208

Review 4.  Prospects for neural stem cell-based therapies for neurological diseases.

Authors:  Jaime Imitola
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

5.  Intravenously delivered neural stem cells migrate into ischemic brain, differentiate and improve functional recovery after transient ischemic stroke in adult rats.

Authors:  Yi Cheng; Jinjing Zhang; Liancheng Deng; Noah R Johnson; Xichong Yu; Ning Zhang; Tianzheng Lou; Yi Zhang; Xiaojie Wei; Zaifeng Chen; Songbin He; Xiaokun Li; Jian Xiao
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 6.  Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.

Authors:  Yossef S Levy; Merav Stroomza; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

7.  Survival, differentiation, and neuroprotective mechanisms of human stem cells complexed with neurotrophin-3-releasing pharmacologically active microcarriers in an ex vivo model of Parkinson's disease.

Authors:  Nicolas Daviaud; Elisa Garbayo; Laurence Sindji; Alberto Martínez-Serrano; Paul C Schiller; Claudia N Montero-Menei
Journal:  Stem Cells Transl Med       Date:  2015-04-29       Impact factor: 6.940

8.  Factors influencing the differentiation of dopaminergic traits in transplanted neural stem cells.

Authors:  Ming Yang; Angela E Donaldson; Yubao Jiang; Lorraine Iacovitti
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

9.  Quantitative evaluation of motor function before and after engraftment of dopaminergic neurons in a rat model of Parkinson's disease.

Authors:  Chieh-Sen Chuang; Hong-Lin Su; Fu-Chou Cheng; Shan-hui Hsu; Chi-Fen Chuang; Chin-San Liu
Journal:  J Biomed Sci       Date:  2010-02-13       Impact factor: 8.410

10.  Synaptic microcircuitry of tyrosine hydroxylase-containing neurons and terminals in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.

Authors:  Maney Mazloom; Yoland Smith
Journal:  J Comp Neurol       Date:  2006-04-01       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.